Arterial ageing: from endothelial dysfunction to vascular calcification

Journal of Internal Medicine

Volumn 281, Issue 5, 2017, Pages 471-482

  Tesauro, M ^a   Mauriello, A ^a   Rovella, V ^a   Annicchiarico Petruzzelli, M ^b   Cardillo, C ^c   Melino, G ^a,d   Di Daniele, N ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

ageing; atherosclerosis; cell death; endothelial plaques; nitric oxide; vascular calcification

Indexed keywords

NITRIC OXIDE;

AGING; ARTERIAL AGING; ARTERIAL STIFFNESS; ARTERY; ARTERY CALCIFICATION; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR PARAMETERS; CONFERENCE PAPER; CORONARY ARTERY CALCIUM SCORE; ENDOTHELIAL DYSFUNCTION; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SHEAR STRESS; VASCULAR SMOOTH MUSCLE CELL; ATHEROSCLEROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

AGING; ARTERIES; ATHEROSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; PLAQUE, ATHEROSCLEROTIC; STRESS, PHYSIOLOGICAL; VASCULAR CALCIFICATION;

EID: 85016549311     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12605     Document Type: Conference Paper

References (131)

1. Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999; 340: 115–26.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685–95.
3. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 1992; 326: 310–8.
4. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20: 1262–75.
5. Spagnoli LG, Bonanno E, Sangiorgi G, Mauriello A. Role of inflammation in atherosclerosis. J Nucl Med 2007; 48: 1800–15.
6. Lopez-Otin C, Galluzzi L, Freije JM, Madeo F, Kroemer G. Metabolic control of longevity. Cell 2016; 166: 802–21.
7. Finkel T. The metabolic regulation of aging. Nat Med 2015; 21: 1416–23.
8. Wang JC, Bennett M. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res 2012; 111: 245–59.
9. Menghini R, Casagrande V, Cardellini M et al. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 2009; 120: 1524–32.
10. Candi E, Amelio I, Agostini M, Melino G. MicroRNAs and p63 in epithelial stemness. Cell Death Differ 2015; 22: 12–21.
11. Fernandez Larrosa PN, Ruiz Grecco M, Mengual Gomez D et al. RAC3 more than a nuclear receptor coactivator: a key inhibitor of senescence that is downregulated in aging. Cell Death Dis 2015; 6: e1902.
12. Gao Q, Chen K, Gao L, Zheng Y, Yang YG. Thrombospondin-1 signaling through CD47 inhibits cell cycle progression and induces senescence in endothelial cells. Cell Death Dis 2016; 7: e2368.
13. Jin H, Lian N, Zhang F et al. Activation of PPARgamma/P53 signaling is required for curcumin to induce hepatic stellate cell senescence. Cell Death Dis 2016; 7: e2189.
14. Lai P, Song Q, Yang C et al. Loss of Rictor with aging in osteoblasts promotes age-related bone loss. Cell Death Dis 2016; 7: e2408.
15. Shao AW, Sun H, Geng Y et al. Bclaf1 is an important NF-kappaB signaling transducer and C/EBPbeta regulator in DNA damage-induced senescence. Cell Death Differ 2016; 23: 865–75.
16. Zhao M, Chen L, Qu H. CSGene: a literature-based database for cell senescence genes and its application to identify critical cell aging pathways and associated diseases. Cell Death Dis 2016; 7: e2053.
17. Filomeni G, De Zio D, Cecconi F. Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ 2015; 22: 377–88.
18. Liu Y, Levine B. Autosis and autophagic cell death: the dark side of autophagy. Cell Death Differ 2015; 22: 367–76.
19. Green DR, Oguin TH, Martinez J. The clearance of dying cells: table for two. Cell Death Differ 2016; 23: 915–26.
20. Rockenfeller P, Koska M, Pietrocola F et al. Phosphatidylethanolamine positively regulates autophagy and longevity. Cell Death Differ 2015; 22: 499–508.
21. Sun Z. Aging, arterial stiffness, and hypertension. Hypertension 2015; 65: 252–6.
22. Nilsson PM. Hemodynamic aging as the consequence of structural changes associated with early vascular aging (EVA). Aging Dis 2014; 5: 109–13.
23. Vanhoutte PM, Zhao Y, Xu A, Leung SW. Thirty years of saying NO: sources, fate, actions, and misfortunes of the endothelium-derived vasodilator mediator. Circ Res 2016; 119: 375–96.
24. Smulyan H, Mookherjee S, Safar ME. The two faces of hypertension: role of aortic stiffness. J Am Soc Hypertens 2016; 10: 175–83.
25. Noce A, Canale MP, Capria A et al. Coronary artery calcifications predict long term cardiovascular events in non diabetic Caucasian hemodialysis patients. Aging (Albany NY) 2015; 7: 269–79.
26. Sell DR, Monnier VM. Molecular basis of arterial stiffening: role of glycation – a mini-review. Gerontology 2012; 58: 227–37.
27. Spina M, Garbisa S, Hinnie J, Hunter JC, Serafini-Fracassini A. Age-related changes in composition and mechanical properties of the tunica media of the upper thoracic human aorta. Arteriosclerosis 1983; 3: 64–76.
28. Mauriello A, Orlandi A, Palmieri G, Spagnoli LG, Oberholzer M, Christen H. Age-related modification of average volume and anisotropy of vascular smooth muscle cells. Pathol Res Pract 1992; 188: 630–6.
29. Nejjar I, Pieraggi MT, Thiers JC, Bouissou H. Age-related changes in the elastic tissue of the human thoracic aorta. Atherosclerosis 1990; 80: 199–208.
30. Mauriello A, Sangiorgi G, Fratoni S et al. Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction. J Am Coll Cardiol 2005; 45: 1585–93.
31. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011; 12: 204–12.
32. Farup J, Madaro L, Puri PL, Mikkelsen UR. Interactions between muscle stem cells, mesenchymal-derived cells and immune cells in muscle homeostasis, regeneration and disease. Cell Death Dis 2015; 6: e1830.
33. Seals DR, Jablonski KL, Donato AJ. Aging and vascular endothelial function in humans. Clin Sci (Lond) 2011; 120: 357–75.
34. Campia U, Tesauro M, Di Daniele N, Cardillo C. The vascular endothelin system in obesity and type 2 diabetes: pathophysiology and therapeutic implications. Life Sci 2014; 118: 149–55.
35. Schinzari F, Iantorno M, Campia U et al. Vasodilator responses and endothelin-dependent vasoconstriction in metabolically healthy obesity and the metabolic syndrome. Am J Physiol Endocrinol Metab 2015; 309: E787–92.
36. Warren DT, Tajsic T, Porter LJ et al. Nesprin-2-dependent ERK1/2 compartmentalisation regulates the DNA damage response in vascular smooth muscle cell ageing. Cell Death Differ 2015; 22: 1540–50.
37. Fitzgerald AL, Osman AA, Xie TX et al. Reactive oxygen species and p21Waf1/Cip1 are both essential for p53-mediated senescence of head and neck cancer cells. Cell Death Dis 2015; 6: e1678.
38. Lehmann S, Costa AC, Celardo I, Loh SH, Martins LM. Parp mutations protect against mitochondrial dysfunction and neurodegeneration in a PARKIN model of Parkinson's disease. Cell Death Dis 2016; 7: e2166.
39. Pinto M, Pickrell AM, Wang X et al. Transient mitochondrial DNA double strand breaks in mice cause accelerated aging phenotypes in a ROS-dependent but p53/p21-independent manner. Cell Death Differ 2017; 24: 288–299.
40. Valenzuela R, Costa-Besada MA, Iglesias-Gonzalez J et al. Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration. Cell Death Dis 2016; 7: e2427.
41. Zhao X, Dong Y, Zhang J et al. Leptin changes differentiation fate and induces senescence in chondrogenic progenitor cells. Cell Death Dis 2016; 7: e2188.
42. Jung SH, Lee HC, Yu DM et al. Heparan sulfation is essential for the prevention of cellular senescence. Cell Death Differ 2016; 23: 417–29.
43. Gradinaru D, Borsa C, Ionescu C, Prada GI. Oxidized LDL and NO synthesis – biomarkers of endothelial dysfunction and ageing. Mech Ageing Dev 2015; 151: 101–13.
44. Michel T, Vanhoutte PM. Cellular signaling and NO production. Pflugers Arch 2010; 459: 807–16.
45. Haldar SM, Stamler JS. S-nitrosylation: integrator of cardiovascular performance and oxygen delivery. J Clin Invest 2013; 123: 101–10.
46. Lima B, Forrester MT, Hess DT, Stamler JS. S-nitrosylation in cardiovascular signaling. Circ Res 2010; 106: 633–46.
47. Nakamura T, Lipton SA. Nitrosative stress in the nervous system: guidelines for designing experimental strategies to study protein S-nitrosylation. Neurochem Res 2016; 41: 510–4.
48. Nakamura T, Lipton SA. Protein S-nitrosylation as a therapeutic target for neurodegenerative diseases. Trends Pharmacol Sci 2016; 37: 73–84.
49. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003; 42: 1149–60.
50. Donato AJ, Morgan RG, Walker AE, Lesniewski LA. Cellular and molecular biology of aging endothelial cells. J Mol Cell Cardiol 2015; 89: 122–35.
51. Iantorno M, Campia U, Di Daniele N et al. Obesity, inflammation and endothelial dysfunction. J Biol Regul Homeost Agents 2014; 28: 169–76.
52. Mitchell GF, Parise H, Benjamin EJ et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 2004; 43: 1239–45.
53. Ji LL, Leeuwenburgh C, Leichtweis S et al. Oxidative stress and aging. Role of exercise and its influences on antioxidant systems. Ann N Y Acad Sci 1998; 854: 102–17.
54. Vgontzas AN, Zoumakis M, Bixler EO et al. Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J Clin Endocrinol Metab 2003; 88: 2087–95.
55. Pitocco D, Tesauro M, Alessandro R, Ghirlanda G, Cardillo C. Oxidative stress in diabetes: implications for vascular and other complications. Int J Mol Sci 2013; 14: 21525–50.
56. Schinzari F, Tesauro M, Rovella V et al. Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome. J Clin Endocrinol Metab 2013; 98: 1235–41.
57. Schinzari F, Tesauro M, Rovella V et al. Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome. Am J Physiol Endocrinol Metab 2010; 299: E947–52.
58. Tesauro M, Schinzari F, Rovella V et al. Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome. Diabetes Care 2008; 31: 1439–41.
59. Tesauro M, Rizza S, Iantorno M et al. Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus. Metabolism 2007; 56: 413–9.
60. Nicotera P, Bernassola F, Melino G. Nitric oxide (NO), a signaling molecule with a killer soul. Cell Death Differ 1999; 6: 931–3.
61. Nicotera P, Melino G. Regulation of the apoptosis-necrosis switch. Oncogene 2004; 23: 2757–65.
62. Liu L, Yan Y, Zeng M et al. Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell 2004; 116: 617–28.
63. Quijano C, Castro L, Peluffo G, Valez V, Radi R. Enhanced mitochondrial superoxide in hyperglycemic endothelial cells: direct measurements and formation of hydrogen peroxide and peroxynitrite. Am J Physiol Heart Circ Physiol 2007; 293: H3404–14.
64. Stamler JS, Hausladen A. Oxidative modifications in nitrosative stress. Nat Struct Biol 1998; 5: 247–9.
65. Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 2005; 6: 150–66.
66. Melino G, Bernassola F, Knight RA, Corasaniti MT, Nistico G, Finazzi-Agro A. S-nitrosylation regulates apoptosis. Nature 1997; 388: 432–3.
67. Catani MV, Bernassola F, Rossi A, Melino G. Inhibition of clotting factor XIII activity by nitric oxide. Biochem Biophys Res Commun 1998; 249: 275–8.
68. Melino G, Bernassola F, Catani MV et al. Nitric oxide inhibits apoptosis via AP-1-dependent CD95L transactivation. Cancer Res 2000; 60: 2377–83.
69. Rossi A, Catani MV, Candi E, Bernassola F, Puddu P, Melino G. Nitric oxide inhibits cornified envelope formation in human keratinocytes by inactivating transglutaminases and activating protein 1. J Invest Dermatol 2000; 115: 731–9.
70. Vieira HL, Belzacq AS, Haouzi D et al. The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene 2001; 20: 4305–16.
71. Stamler JS, Lamas S, Fang FC. Nitrosylation. The prototypic redox-based signaling mechanism. Cell 2001; 106: 675–83.
72. Melino G, Catani MV, Corazzari M, Guerrieri P, Bernassola F. Nitric oxide can inhibit apoptosis or switch it into necrosis. Cell Mol Life Sci 2000; 57: 612–22.
73. van der Loo B, Labugger R, Skepper JN et al. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 2000; 192: 1731–44.
74. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004; 39: 687–99.
75. Golomb L, Sagiv A, Pateras IS et al. Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy. Cell Death Differ 2015; 22: 1764–74.
76. Ungvari Z, Kaley G, de Cabo R, Sonntag WE, Csiszar A. Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci 2010; 65: 1028–41.
77. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 2014; 69(Suppl 1): S4–9.
78. Donato AJ, Magerko KA, Lawson BR, Durrant JR, Lesniewski LA, Seals DR. SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans. J Physiol 2011; 589: 4545–54.
79. Xin MG, Zhang J, Block ER, Patel JM. Senescence-enhanced oxidative stress is associated with deficiency of mitochondrial cytochrome c oxidase in vascular endothelial cells. Mech Ageing Dev 2003; 124: 911–9.
80. Krouwer VJ, Hekking LH, Langelaar-Makkinje M, Regan-Klapisz E, Post JA. Endothelial cell senescence is associated with disrupted cell-cell junctions and increased monolayer permeability. Vasc Cell 2012; 4: 12.
81. Movat HZ, More RH, Haust MD. The diffuse intimal thickening of the human aorta with aging. Am J Pathol 1958; 34: 1023–31.
82. Stary HC. Macrophages, macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children. Atherosclerosis 1987; 64: 91–108.
83. Friedman MH. A biologically plausible model of thickening of arterial intima under shear. Arteriosclerosis 1989; 9: 511–22.
84. Orlandi A, Mauriello A, Marino B, Spagnoli LG. Age-related modifications of aorta and coronaries in the rabbit: a morphological and morphometrical assessment. Arch Gerontol Geriatr 1993; 17: 37–53.
85. Spagnoli LG, Orlandi A, Mauriello A, De Angelis C, Ramacci MT. Age-dependent increase of rabbit aortic atherosclerosis. A morphometric approach. Pathol Res Pract 1992; 188: 637–42.
86. Spagnoli LG, Orlandi A, Mauriello A et al. Aging and atherosclerosis in the rabbit. 1. Distribution, prevalence and morphology of atherosclerotic lesions. Atherosclerosis 1991; 89: 11–24.
87. Porreca E, Ciccarelli R, Di Febbo C, Cuccurullo F. Protein kinase C pathway and proliferative responses of aged and young rat vascular smooth muscle cells. Atherosclerosis 1993; 104: 137–45.
88. Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res 2016; 118: 692–702.
89. McCaffrey TA, Nicholson AC, Szabo PE, Weksler ME, Weksler BB. Aging and arteriosclerosis. The increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity. J Exp Med 1988; 167: 163–74.
90. Stemerman MB, Weinstein R, Rowe JW, Maciag T, Fuhro R, Gardner R. Vascular smooth muscle cell growth kinetics in vivo in aged rats. Proc Natl Acad Sci USA 1982; 79: 3863–6.
91. Orlandi A, Ropraz P, Gabbiani G. Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-beta 1 and heparin. Exp Cell Res 1994; 214: 528–36.
92. McCaffrey TA, Falcone DJ. Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-beta in vascular smooth muscle cells. Mol Biol Cell 1993; 4: 315–22.
93. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004; 84: 767–801.
94. Iyemere VP, Proudfoot D, Weissberg PL, Shanahan CM. Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med 2006; 260: 192–210.
95. Wolinsky H. Long-term effects of hypertension on the rat aortic wall and their relation to concurrent aging changes. Morphological and chemical studies. Circ Res 1972; 30: 301–9.
96. Rubio-Ruiz ME, Perez-Torres I, Soto ME, Pastelin G, Guarner-Lans V. Aging in blood vessels. Medicinal agents FOR systemic arterial hypertension in the elderly. Ageing Res Rev 2014; 18: 132–47.
97. Zhao Y, Vanhoutte PM, Leung SW. Vascular nitric oxide: Beyond eNOS. J Pharmacol Sci 2015; 129: 83–94.
98. Faggiotto A, Ross R. Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 1984; 4: 341–56.
99. Lakatta EG. So! What's aging? Is cardiovascular aging a disease? J Mol Cell Cardiol 2015; 83: 1–13.
100. Kwak BR, Back M, Bochaton-Piallat ML et al. Biomechanical factors in atherosclerosis: mechanisms and clinical implications. Eur Heart J 2014; 35: 3013–20, 20a–20d.
101. Carallo C, Tripolino C, De Franceschi MS, Irace C, Xu XY, Gnasso A. Carotid endothelial shear stress reduction with aging is associated with plaque development in twelve years. Atherosclerosis 2016; 251: 63–9.
102. Cuhlmann S, Van der Heiden K, Saliba D et al. Disturbed blood flow induces RelA expression via c-Jun N-terminal kinase 1: a novel mode of NF-kappa B regulation that promotes arterial inflammation. Circ Res 2011; 108: 950–9.
103. Xiao H, Lu M, Lin TY et al. Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility. Circulation 2013; 128: 632–42.
104. Menghini R, Stohr R, Federici M. MicroRNAs in vascular aging and atherosclerosis. Ageing Res Rev 2014; 17: 68–78.
105. Gupta SK, Piccoli MT, Thum T. Non-coding RNAs in cardiovascular ageing. Ageing Res Rev 2014; 17: 79–85.
106. Spagnoli LG, Mauriello A, Palmieri G, Santeusanio G, Amante A, Taurino M. Relationships between risk factors and morphological patterns of human carotid atherosclerotic plaques. A multivariate discriminant analysis. Atherosclerosis 1994; 108: 39–60.
107. van Oostrom O, Velema E, Schoneveld AH et al. Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis. Cardiovasc Pathol 2005; 14: 126–34.
108. Mauriello A, Sangiorgi GM, Virmani R et al. A pathobiologic link between risk factors profile and morphological markers of carotid instability. Atherosclerosis 2010; 208: 572–80.
109. Redgrave JN, Lovett JK, Rothwell PM. Histological features of symptomatic carotid plaques in relation to age and smoking: the oxford plaque study. Stroke 2010; 41: 2288–94.
110. van Lammeren GW, Reichmann BL, Moll FL et al. Atherosclerotic plaque vulnerability as an explanation for the increased risk of stroke in elderly undergoing carotid artery stenting. Stroke 2011; 42: 2550–5.
111. Grufman H, Schiopu A, Edsfeldt A et al. Evidence for altered inflammatory and repair responses in symptomatic carotid plaques from elderly patients. Atherosclerosis 2014; 237: 177–82.
112. Xia S, Zhang X, Zheng S et al. An update on inflamm-aging: mechanisms, prevention, and treatment. J Immunol Res 2016; 2016: 8426874.
113. Franceschi C, Bonafe M, Valensin S et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908: 244–54.
114. Bruunsgaard H, Andersen-Ranberg K, Hjelmborg J, Pedersen BK, Jeune B. Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med 2003; 115: 278–83.
115. Yang Y, Lv J, Jiang S et al. The emerging role of Toll-like receptor 4 in myocardial inflammation. Cell Death Dis 2016; 7: e2234.
116. Gao F, Chiu SM, Motan DA et al. Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis 2016; 7: e2062.
117. Zhao H, Jaffer T, Eguchi S, Wang Z, Linkermann A, Ma D. Role of necroptosis in the pathogenesis of solid organ injury. Cell Death Dis 2015; 6: e1975.
118. Humphries F, Yang S, Wang B, Moynagh PN. RIP kinases: key decision makers in cell death and innate immunity. Cell Death Differ 2015; 22: 225–36.
119. Galluzzi L, Bravo-San Pedro JM, Vitale I et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ 2015; 22: 58–73.
120. McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2006; 113: 30–7.
121. McClelland RL, Jorgensen NW, Budoff M et al. 10-Year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors: derivation in the mesa (multi-ethnic study of atherosclerosis) with validation in the HNR (heinz nixdorf recall) study and the DHS (dallas heart study). J Am Coll Cardiol 2015; 66: 1643–53.
122. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol 2005; 46: 158–65.
123. Tota-Maharaj R, Blaha MJ, Rivera JJ et al. Differences in coronary plaque composition with aging measured by coronary computed tomography angiography. Int J Cardiol 2012; 158: 240–5.
124. Kwee RM. Systematic review on the association between calcification in carotid plaques and clinical ischemic symptoms. J Vasc Surg 2010; 51: 1015–25.
125. Wendorff C, Wendorff H, Pelisek J et al. Carotid plaque morphology is significantly associated with sex, age, and history of neurological symptoms. Stroke 2015; 46: 3213–9.
126. Alexopoulos N, Raggi P. Calcification in atherosclerosis. Nat Rev Cardiol 2009; 6: 681–8.
127. Sangiorgi G, Rumberger JA, Severson A et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 1998; 31: 126–33.
128. Mauriello A, Servadei F, Zoccai GB et al. Coronary calcification identifies the vulnerable patient rather than the vulnerable Plaque. Atherosclerosis 2013; 229: 124–9.
129. Demer LL, Tintut Y. Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler Thromb Vasc Biol 2014; 34: 715–23.
130. Virmani R, Joner M, Sakakura K. Recent highlights of ATVB: calcification. Arterioscler Thromb Vasc Biol 2014; 34: 1329–32.
131. New SE, Aikawa E. Role of extracellular vesicles in de novo mineralization: an additional novel mechanism of cardiovascular calcification. Arterioscler Thromb Vasc Biol 2013; 33: 1753–8.